Inflection Biosciences Ltd is an early stage, drug development company with a focus on discovering and developing innovative small molecule therapeutics addressing major unmet needs in cancer.
View all
Flow Robotics
Copenhagen, Denmark
BioMarin Pharmaceutical
Post IPO Debt • San Rafael, United States
Prothena
Post IPO Equity • Dublin 4, Ireland
Verve Therapeutics
Series B • Cambridge, United States
BenevolentAI
Private Equity • England, United Kingdom
Biogen
Cambridge, United States
Imvax
Series C • Philadelphia, United States
Guardant Health
Venture • Redwood City, United States
Genentech
Venture • South San Francisco, United States
Celsius Therapeutics
Series B • Cambridge, United States
ARCA biopharma
Westminster, United States
Alkermes
Post IPO Equity • Dublin 4, Ireland